Eckburg Paul - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 15, 2024, Eckburg Paul's relationship to AN2 Therapeutics, Inc. (ANTX) is Officer (Chief Medical Officer), and currently has 51,416 shares of Common Stock, and 51,416 shares of Common.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Eckburg Paul - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 16, 2024 | Acquisition -- (Common Stock) | 30000 | 0 | 51416 |
| Mar 16, 2024 | Acquisition -- (Common) | 30000 | 0 | 51416 |